01 1Changzhou Pharmaceutical Factory
01 1CAPTOPRIL
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-08-15
Pay. Date : 2019-06-20
DMF Number : 33888
Submission : 2019-05-22
Status : Active
Type : II
20
Changzhou Pharmaceutical Factory, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CAPTOPRIL, with a corresponding US DMF Number 33888.
Remarkably, this DMF maintains an Active status since its submission on May 22, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 15, 2019, and payment made on June 20, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
